BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28742252)

  • 21. Data-Adaptive Bias-Reduced Doubly Robust Estimation.
    Vermeulen K; Vansteelandt S
    Int J Biostat; 2016 May; 12(1):253-82. PubMed ID: 27227724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine learning outcome regression improves doubly robust estimation of average causal effects.
    Choi BY; Wang CP; Gelfond J
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1120-1133. PubMed ID: 32716126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doubly robust nonparametric instrumental variable estimators for survival outcomes.
    Lee Y; Kennedy EH; Mitra N
    Biostatistics; 2023 Apr; 24(2):518-537. PubMed ID: 34676400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doubly-robust methods for differences in restricted mean lifetimes using pseudo-observations.
    Choi S; Choi T; Lee HY; Han SW; Bandyopadhyay D
    Pharm Stat; 2022 Nov; 21(6):1185-1198. PubMed ID: 35524651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmented Inverse Probability Weighting and the Double Robustness Property.
    Kurz CF
    Med Decis Making; 2022 Feb; 42(2):156-167. PubMed ID: 34225519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weighted estimation of the accelerated failure time model in the presence of dependent censoring.
    Cho Y; Ghosh D
    PLoS One; 2015; 10(4):e0124381. PubMed ID: 25909753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Machine Learning for Causal Inference: On the Use of Cross-fit Estimators.
    Zivich PN; Breskin A
    Epidemiology; 2021 May; 32(3):393-401. PubMed ID: 33591058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring.
    Latimer NR; Abrams KR; Siebert U
    BMC Med Res Methodol; 2019 Mar; 19(1):69. PubMed ID: 30935369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A quantile regression model for failure-time data with time-dependent covariates.
    Gorfine M; Goldberg Y; Ritov Y
    Biostatistics; 2017 Jan; 18(1):132-146. PubMed ID: 27485534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating population treatment effects from a survey subsample.
    Rudolph KE; Díaz I; Rosenblum M; Stuart EA
    Am J Epidemiol; 2014 Oct; 180(7):737-48. PubMed ID: 25190679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-varying effect moderation using the structural nested mean model: estimation using inverse-weighted regression with residuals.
    Almirall D; Griffin BA; McCaffrey DF; Ramchand R; Yuen RA; Murphy SA
    Stat Med; 2014 Sep; 33(20):3466-87. PubMed ID: 23873437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subclassification estimation of the weighted average treatment effect.
    Choi BY
    Biom J; 2021 Dec; 63(8):1706-1728. PubMed ID: 34270815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring.
    Dong G; Mao L; Huang B; Gamalo-Siebers M; Wang J; Yu G; Hoaglin DC
    J Biopharm Stat; 2020 Sep; 30(5):882-899. PubMed ID: 32552451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.
    Schaubel DE; Wei G
    Biometrics; 2011 Mar; 67(1):29-38. PubMed ID: 20560935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AIPW: An R Package for Augmented Inverse Probability-Weighted Estimation of Average Causal Effects.
    Zhong Y; Kennedy EH; Bodnar LM; Naimi AI
    Am J Epidemiol; 2021 Dec; 190(12):2690-2699. PubMed ID: 34268567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mediation Analysis for Censored Survival Data Under an Accelerated Failure Time Model.
    Fulcher IR; Tchetgen Tchetgen EJ; Williams PL
    Epidemiology; 2017 Sep; 28(5):660-666. PubMed ID: 28574921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation.
    Gabriel EE; Sachs MC; Martinussen T; Waernbaum I; Goetghebeur E; Vansteelandt S; Sjölander A
    Stat Med; 2024 Feb; 43(3):534-547. PubMed ID: 38096856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of accelerated failure time data with dependent censoring using auxiliary variables via nonparametric multiple imputation.
    Hsu CH; Taylor JM; Hu C
    Stat Med; 2015 Aug; 34(19):2768-80. PubMed ID: 25999295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted maximum likelihood based causal inference: Part I.
    van der Laan MJ
    Int J Biostat; 2010; 6(2):Article 2. PubMed ID: 21969992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjustment for Baseline Covariates to Increase Efficiency in RCTs with Binary Endpoint: A Comparison of Bayesian and Frequentist Approaches.
    Berchialla P; Sciannameo V; Urru S; Lanera C; Azzolina D; Gregori D; Baldi I
    Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.